S. Stilgenbauer Et Al. , "Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study," BRITISH JOURNAL OF HAEMATOLOGY , vol.193, no.2, pp.325-338, 2021
Stilgenbauer, S. Et Al. 2021. Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study. BRITISH JOURNAL OF HAEMATOLOGY , vol.193, no.2 , 325-338.
Stilgenbauer, S., Bosch, F., Ilhan, O., Kisro, J., Mahe, B., Mikuskova, E., ... Osmanov, D.(2021). Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study. BRITISH JOURNAL OF HAEMATOLOGY , vol.193, no.2, 325-338.
Stilgenbauer, Stephan Et Al. "Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study," BRITISH JOURNAL OF HAEMATOLOGY , vol.193, no.2, 325-338, 2021
Stilgenbauer, Stephan Et Al. "Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study." BRITISH JOURNAL OF HAEMATOLOGY , vol.193, no.2, pp.325-338, 2021
Stilgenbauer, S. Et Al. (2021) . "Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study." BRITISH JOURNAL OF HAEMATOLOGY , vol.193, no.2, pp.325-338.
@article{article, author={Stephan Stilgenbauer Et Al. }, title={Safety and efficacy of obinutuzumab alone or with chemotherapy in previously untreated or relapsed/refractory chronic lymphocytic leukaemia patients: Final analysis of the Phase IIIb GREEN study}, journal={BRITISH JOURNAL OF HAEMATOLOGY}, year=2021, pages={325-338} }